Ann: RELINT: FPH: Disclosure of Officer Relevant Interests

• Release Date: 17/07/14 12:46
• Summary: RELINT: FPH: Disclosure of Officer Relevant Interests
• Price Sensitive: No
• Download Document  1.42KB

					FPH
17/07/2014 12:46
RELINT

REL: 1246 HRS Fisher & Paykel Healthcare Corporation Limited

RELINT: FPH: Disclosure of Officer Relevant Interests

Name of director or officer of public issuer:  Paul ANDREASSI
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable):  Not Applicable
Position held in public issuer:  Vice President Quality & Regulatory

B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities:   Sale of 9,864 Ordinary Shares

C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities:   Beneficial interest
Name of registered holder of securities   Paul ANDREASSI

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition:  Not Applicable
Consideration paid for acquisition: Not Applicaable

If the relevant interest was disposed of--
Date of disposal:    16 July 2014
Consideration received for disposal:   $45,768.96

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition or disposal took place:   Sale of 9,864 Ordinary Shares

E Total number of transactions this notice relates to:  One

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer:   6 June 2014
End CA:00252817 For:FPH    Type:RELINT     Time:2014-07-17 12:46:12